CSIMarket
 
Angiodynamics Inc   (NASDAQ: ANGO)
 

Angiodynamics Inc's Suppliers Performance

ANGO's Supply Chain




 
ANGO Costs vs Sales of Suppliers Growth Angiodynamics Inc recorded an increase in cost of sales by 2.14 % year on year, sequentially cost of sales grew by 10.65 % in Q4.

• More on ANGO Suppliers



Angiodynamics Inc recorded increase in cost of sales by 2.14 % year on year, sequentially cost of sales grew by 10.65 % in Q4.

• More on ANGO Suppliers




Angiodynamics Inc's Comment on Supply Chain


AngioDynamics sources raw materials that are assembled and tested to comply with regulatory standards and internal specifications. Manufacturing occurs at both company-owned and third-party facilities registered with the FDA and certified to ISO 13485 standards, supporting sales within European Union countries. The company holds certification under the Medical Device Single Audit Program (MDSAP), enabling a single regulatory audit to meet requirements of multiple international authorities, including those in Australia, Brazil, Canada, Japan, and the United States. Manufacturing sites undergo regular inspections to ensure adherence to domestic and international regulations. AngioDynamics maintains sufficient inventory to enable product shipment within 24 to 48 hours and has established safety stock to reduce backlog risks during manufacturing transitions to Costa Rica and other partners.

Angiodynamics Inc's Comment on Supply Chain


AngioDynamics sources raw materials that are assembled and tested to comply with regulatory standards and internal specifications. Manufacturing occurs at both company-owned and third-party facilities registered with the FDA and certified to ISO 13485 standards, supporting sales within European Union countries. The company holds certification under the Medical Device Single Audit Program (MDSAP), enabling a single regulatory audit to meet requirements of multiple international authorities, including those in Australia, Brazil, Canada, Japan, and the United States. Manufacturing sites undergo regular inspections to ensure adherence to domestic and international regulations. AngioDynamics maintains sufficient inventory to enable product shipment within 24 to 48 hours and has established safety stock to reduce backlog risks during manufacturing transitions to Costa Rica and other partners.







ANGO's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Angiodynamics Inc 643.23 317.73 -36.74 632
SUBTOTAL 0.00 0.00 0.00 -


Sources: Angiodynamics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Angiodynamics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.